Home/ Stocks/ NCNA

NuCana plc American Depositary Share

NCNA XNAS

$0.94 +0.03 (+3.23%) ▲ 15-min delayed

Open

$0.95

High

$0.95

Low

$0.90

Volume

20.2K

Market Cap

$3.90M

About NuCana plc American Depositary Share

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.

Employees: 12 Website →

Related Market News

No specific coverage for NCNA yet. Check out our latest market news or earnings calendar.

Get NCNA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on NuCana plc American Depositary Share.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.